KRTL BioTech

Hedge fund Glenview off 30% as coronavirus weighs on portfolio

Hedge fund Glenview off 30% as coronavirus weighs on portfolio

Glenview Capital Management, the hedge fund run by Larry Robbins, has lost roughly 30% in the first three months of 2020 as the spread of the new coronavirus hurt the healthcare facilities and hospital operators the firm has invested in.